Human minibrains reveal effects of psychedelic substance

Publications

Dr. Hauser is an accomplished physician and researcher who has authored or co-authored more than 400 peer-reviewed publications. His work covers a wide range of topics, including Parkinson’s disease, essential tremors, and cutting-edge medication. Dr. Hauser's extensive contributions have significantly advanced the field of neurology and improved treatment options for patients. His dedication to research continues to drive innovations in medical science.

Connors, JJ, D Sacks, AJ Furlan, WR Selman, RA Hauser, and . 2009. “Training, Competency, and Credentialing Standards for Diagnostic Cervicocerebral Angiography, Carotid Stenting, and Cerebrovascular Intervention: A Joint Statement from the American Academy of Neurology, . ”. J Vasc Interv Radiol.
Hauser, RA, KE Lyons, T McClain, S Carter, and D Perlmutter. 2009. “Randomized, Double-Blind, Pilot Evaluation of Intravenous Glutathione in Parkinson’s Disease”. Mov Disord.
Hauser, RA, MF Lew, HI Hurtig, WG Ondo, J Wojcieszek, and CJ Fitzer-Attas. 2009. “TEMPO Open-Label Study Group. Long-Term Outcome of Early versus Delayed Rasagiline Treatment in Early Parkinson’s Disease.”. Mov Disord.
Hauser, RA, M Panisset, G Abbruzzese, L Mancione, N Dronamraju, and A Kakarieka. 2009. “Double-Blind Trial of Levodopa/Carbidopa/Entacapone versus Levodopa/Carbidopa in Early Parkinson’s Disease”. Mov Disord.
Zesiewicz, TA, RA Hauser, A Freeman, KL Sullivan, AM Miller, and T Halim. 2009. “Fentanyl-Induced Bradykinesia and Rigidity After Deep Brain Stimulation in a Patient With Parkinson Disease”. Clin Neuropharmacol.
Hauser, RA. 2009. “Levodopa: Past, Present, and Future”. Eur Neurol.

More publications